Melanoma--diagnosis by telemedicine

Teleoncology: current and future applications for improving cancer care globally

Access to quality cancer care is often unavailable in low-income and middle-income countries, and also in rural or remote areas of high-income countries. Teleoncology-oncology applications of medical telecommunications, including pathology, radiology, and other related disciplines-has the potential to enhance access to and quality of clinical cancer care, and to improve education and training. Implementation of teleoncology in the developing world requires an approach tailored to priorities, resources, and needs. Teleoncology can best achieve its proposed goals through consistent and long-term application. We review teleoncology initiatives that have the potential to decrease cancer-care inequality between resource-poor and resource-rich institutions and offer guidelines for the development of teleoncology programmes in low-income and middle-income countries.

Championing telemedicine adoption and utilization in healthcare organizations in New Zealand

BACKGROUND/OBJECTIVES

This research explored the adoption and the utilisation of telemedicine (TM) in two healthcare organizations (HCOs) in New Zealand (NZ). The research utilised the technological innovation theories, as a guiding theoretical framework, to develop a set of potential determinants which could assist in understanding the adoption and the depth of the TM phenomenon in the two HCOs.

METHODOLOGY AND RESULTS

Using case studies design, the findings across the two cases revealed that TM was adopted according to its cost-benefit analysis. Although this approach was found to be important in assessing the adoption of TM, not considering the importance of other factors, highlighted in this research, such as the compatibility and the trialability aspects of the TM technology had a detrimental impact on the success of TM in both cases.

CONCLUSION

This research stressed the need for the tight coupling between the roles of both the administrative and the clinical managers in HCOs in order to champion TM adoption and diffusion and to overcome many of the barriers that could hinder telemedicine success in HCOs in NZ. The research points to other implications with respect to the literature and highlights further research in this important area.

Critical success factors for strategic telemedicine planning in New Zealand

This research reviewed the health information systems (HIS) strategy of the New Zealand government and highlighted different gaps in the strategy, as raised by the different stakeholders involved in this strategy. To address such gaps, the government provided different critical success factors (CSFs) for the successful implementation of the national HIS strategy. The research assessed the strategic importance of telemedicine by highlighting its strengths, weaknesses, opportunities, and threats (SWOT) in health-care organizations. The research utilized the portrayed HIS strategy and CSFs to depict a strategy for telemedicine integration in health-care organizations in New Zealand taking into consideration its SWOT. The developed CSFs are of strategic importance to health-care professionals, researchers, and policymakers interested in integrating telemedicine in health-care delivery at the national level in New Zealand and elsewhere.

Teledermatology: the case of adoption and diffusion of telemedicine health Waikato in New Zealand

Telemedicine emerged as a possible solution to New Zealand health providers in reaching out to rural patients, by offering medical services and conducting administrative meetings and training. However, despite the rapid growth and high visibility of these projects in countries like the United States, relatively few patients are now being seen through telemedicine. Accordingly, this research attempts to investigate telemedicine's effectiveness in New Zealand by using a theoretical framework. Thus, the purpose of this paper is to explain factors influencing the adoption and diffusion of telemedicine utilising the video conferencing technology (TMVC) for dermatology within Health Waikato Ltd. (HW). Findings indicate weak presence of critical assessment into technological innovation prior to adoption. Factors like complexity, compatibility, and trialability were not assessed extensively by HW, and would have hindered its adoption. Teledermatology was mainly assessed according to its relative advantage and cost effectiveness. While essential this should be alongside other factors pertaining to as addressed within this research. On the other hand, the wide diffusion of teledermatology relied on its economical benefit to HW and on its effectiveness as a diagnostic tool. This research highlights the importance of the product champion for the successful adoption and diffusion of teledermatology.